Bausch Health Companies Inc. Inventory Valuation Reserves
Bausch Health Companies Inc. (BHC) had Inventory Valuation Reserves of $112.90 million as of 2014-12-31, per its 10-K filed 2015-02-25.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:InventoryValuationReserves · last filed 2015-02-25
- 2014-12-31: Inventory Valuation Reserves $112.90M.
- 2014-09-30: Inventory Valuation Reserves $113.80M.
- 2014-06-30: Inventory Valuation Reserves $114.50M.
- 2014-03-31: Inventory Valuation Reserves $107.10M.
| Period end | Inventory Valuation Reserves | Inventory Valuation Reserves as first filed |
|---|---|---|
| 2014-12-31 | $112.90M 10-K · filed 2015-02-25 | |
| 2014-09-30 | $113.80M 10-Q · filed 2014-10-24 | |
| 2014-06-30 | $114.50M 10-Q · filed 2014-08-01 | |
| 2014-03-31 | $107.10M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $99.80M 10-K · filed 2015-02-25 | $99.84M 10-K · filed 2014-02-28 |
| 2013-09-30 | $96.34M 10-Q · filed 2013-11-01 | |
| 2013-06-30 | $58.10M 10-Q · filed 2013-08-07 | |
| 2013-03-31 | $59.51M 10-Q · filed 2013-05-03 | |
| 2012-12-31 | $56.03M 10-K · filed 2014-02-28 | |
| 2012-09-30 | $47.34M 10-Q · filed 2012-11-05 | |
| 2012-06-30 | $45.89M 10-Q · filed 2012-08-03 | |
| 2012-03-31 | $31.90M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $22.82M 10-K · filed 2013-02-28 | |
| 2011-09-30 | $21.14M 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $19.10M 10-Q · filed 2011-08-08 | |
| 2010-12-31 | $28.07M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |